SCHEMBL19669737

SCHEMBL19669737

CC(C)(I)NC(=O)/C=C/CN1CCC(N2CCNCC2)CC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.32
ERBB2 P04626 1/20 0.32
SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18030989 0.90 EGFR (0.33) EGFRERBB2SIGMAR1
SCHEMBL19669735 0.86 KDM4E (0.37) EGFRERBB2
SCHEMBL15600978 0.85 EGFR (0.34) EGFRERBB2SIGMAR1
SCHEMBL19669759 0.76 ALDH1A1 (0.39) EGFRERBB2
SCHEMBL24637164 0.76 SIGMAR1 (0.36) EGFRERBB2SIGMAR1
SCHEMBL19669736 0.74 MEN1 (0.45) EGFRERBB2
SCHEMBL19669934 0.72 SIGMAR1 (0.39) EGFRSIGMAR1
SCHEMBL20235763 0.70 ACKR3 (0.35) EGFRERBB2
SCHEMBL15600964 0.69 KDM4E (0.41) EGFRERBB2
SCHEMBL16665113 0.69 SIGMAR1 (0.38) EGFRERBB2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9834571-B2 Compounds for inhibiting cell proliferation in EGFR-driven cancers ARIAD PHARMACEUTICALS, INC. (US) 2017-12-05 US disclosed